NYSE: EVMNEvommune Inc Stock Ownership - Who owns Evommune?
Insider buying vs selling
Have Evommune Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Lorne Hopfner | Director | 2025-12-19 | 1,000 | $17.35 | $17.35kBuy |
| Kyle Carver | Chief Financial Officer | 2025-12-09 | 13,290 | $17.84 | $237.09kSell |
| Janice Suzann Drew | EVP Operations | 2025-12-09 | 5,074 | $17.84 | $90.52kSell |
| Eugene Bauer | Chief Medical Officer | 2025-12-09 | 1,478 | $17.84 | $26.37kSell |
| Gregory S. Moss | Chief Business Legal Officer | 2025-12-09 | 13,624 | $17.84 | $243.05kSell |
| Jeegar Pravinkumar Patel | Chief Scientific Officer | 2025-12-09 | 7,513 | $17.84 | $134.03kSell |
| Luis C. Pena | President CEO | 2025-12-09 | 28,138 | $17.84 | $501.98kSell |
| Weegen Felice Isabel Verduynvan | Director | 2025-11-07 | 1,562,500 | $16.00 | $25.00MBuy |
| 7. Cooperative Ua Lsp | 10% Owner | 2025-11-07 | 1,562,500 | $16.00 | $25.00MBuy |
| Ra Capital Management LP | Director | 2025-11-07 | 1,157,096 | $16.00 | $18.51MBuy |
EVMN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EVMN insiders and whales buy or sell their stock.
EVMN Shareholders
What type of owners hold Evommune Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| 7. Cooperative Ua Lsp | 15.64% | 4,929,633 | $86.71M | Insider |
| Weegen Felice Isabel Verduynvan | 15.64% | 4,929,633 | $86.71M | Insider |
| Robert Lorne Hopfner | 10.70% | 3,372,001 | $59.31M | Insider |
| Ra Capital Management LP | 2.49% | 784,345 | $13.80M | Insider |
| Luis C. Pena | 2.08% | 654,683 | $11.52M | Insider |
| Pivotal Bioventure Partners Fund I LP | 0.93% | 294,502 | $5.18M | Insider |
| Eugene Bauer | 0.86% | 270,818 | $4.76M | Insider |
| Janice Suzann Drew | 0.22% | 67,794 | $1.19M | Insider |
| Gregory S. Moss | 0.20% | 64,010 | $1.13M | Insider |
| Kyle Carver | 0.20% | 62,510 | $1.10M | Insider |
EVMN vs Biotech Stocks
Evommune Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.